Bradley Hittle

The Ohio State University

Papers

3

Total Citations

56

H-Index

3

About

Bradley Hittle is a researcher working at the intersection of cell biology, biomedical engineering, and laboratory automation, with a particular focus on advancing induced pluripotent stem cell (iPSC) technologies for therapeutic applications. His most impactful work centers on automating iPSC generation and manufacturing processes, addressing one of the most significant bottlenecks in translating regenerative medicine from the laboratory to the clinic. His 2023 paper on automating iPSC generation for autologous photoreceptor cell replacement therapy — already accumulating 30 citations — tackles inherited retinal degeneration, a leading cause of irreversible vision loss, by developing high-throughput parallel production systems previously unavailable commercially. Hittle has also made notable contributions to automated colony segmentation of hiPSCs and in-process characterization and selection of cell clones, improving reproducibility and quality control in clinical-grade cell manufacturing. Collectively, his work bridges the gap between cutting-edge stem cell science and the practical engineering solutions needed for scalable, standardized cell therapies. With a growing citation record across multiple publications, Hittle is establishing himself as a key contributor to the future of automated, personalized regenerative medicine.

Research Focus

Key Achievements

3
H-Index
3
Papers
56
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Automating iPSC generation to enable autologous photoreceptor cell replacement therapy
30 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: The Ohio State University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago